US5098373A - Process for controlling blood pumps in the extra-corporeal circuit of a single needle arrangement and apparatus thereof - Google Patents
Process for controlling blood pumps in the extra-corporeal circuit of a single needle arrangement and apparatus thereof Download PDFInfo
- Publication number
- US5098373A US5098373A US07/552,782 US55278290A US5098373A US 5098373 A US5098373 A US 5098373A US 55278290 A US55278290 A US 55278290A US 5098373 A US5098373 A US 5098373A
- Authority
- US
- United States
- Prior art keywords
- pump
- pressure
- venous
- arterial
- accordance
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000008280 blood Substances 0.000 title claims abstract description 31
- 210000004369 blood Anatomy 0.000 title claims abstract description 31
- 238000000034 method Methods 0.000 title claims abstract description 25
- 230000008569 process Effects 0.000 title claims abstract description 21
- 238000005086 pumping Methods 0.000 claims abstract description 14
- 230000004913 activation Effects 0.000 claims description 23
- 230000006872 improvement Effects 0.000 claims description 15
- 230000001419 dependent effect Effects 0.000 claims description 7
- 230000004872 arterial blood pressure Effects 0.000 claims description 3
- 230000000694 effects Effects 0.000 description 6
- 230000001105 regulatory effect Effects 0.000 description 6
- 206010016717 Fistula Diseases 0.000 description 5
- 238000000502 dialysis Methods 0.000 description 5
- 230000003890 fistula Effects 0.000 description 5
- 230000002209 hydrophobic effect Effects 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 230000008901 benefit Effects 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 238000011144 upstream manufacturing Methods 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 230000011218 segmentation Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/30—Single needle dialysis ; Reciprocating systems, alternately withdrawing blood from and returning it to the patient, e.g. single-lumen-needle dialysis or single needle systems for hemofiltration or pheresis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/30—Single needle dialysis ; Reciprocating systems, alternately withdrawing blood from and returning it to the patient, e.g. single-lumen-needle dialysis or single needle systems for hemofiltration or pheresis
- A61M1/301—Details
- A61M1/302—Details having a reservoir for withdrawn untreated blood
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/30—Single needle dialysis ; Reciprocating systems, alternately withdrawing blood from and returning it to the patient, e.g. single-lumen-needle dialysis or single needle systems for hemofiltration or pheresis
- A61M1/301—Details
- A61M1/305—Control of inversion point between collection and re-infusion phase
- A61M1/306—Pressure control, e.g. using substantially rigid closed or gas buffered or elastic reservoirs
Definitions
- the invention has been developed from a process for the control of blood pumps in an extra-corporeal circuit of a single needle arrangement as is known from the Journal Medizintechnik, Vol. 106, S/86, pages 146 to 148 and is also directed to an apparatus therefor. It is particularly suitable for an extra-corporeal dialysis circuit.
- Previously known arrangements utilize either one or two pumps and additionally, one or more clamps, wherein procedures are known wherein the dialyzer is provided with between two pumps or in which it is provided downstream from the venous pump.
- additional chambers partially filled with air which can take the form of a surge tank, or expansion chamber, or bags, which can be provided before the arterial pump, between the pumps, or after the venous pump.
- controls are known whose activation is are time-time dependent, pressure-pressure dependent, pressure-time dependent, volume-volume dependent, or pressure-volume dependent.
- a single canula or a monolumenar catheter which is connected to the patient. From this canula or catheter, arterial and venous portions of the tube system are branched off, wherein these branches can be uncoupled from the rest of the system, either by an occluding pump or by a clamp. Furthermore, it is common to all arrangements that a more or less greater part of the already dialyzed blood is again pumped into the extra-corporeal circuit before the dialyzed blood returns to the body. This procedure is known as recirculation. It is discussed in considerable detail in the Journal "Medical and Biological Engineering and Computing", Volume 17, September, 1989, pages 578 to 582.
- the recirculation of the blood can have several causes. Reference will be made to the conditions in the fistula. Different streaming conditions will occur depending upon whether the determinative flow resistance to the blood stream is upstream, that is to say, on the arterial side or downstream, that is to say, on the venous side of the fistula. If the resistance is arterial, then during the arterial pumping phase, more blood is removed from the fistula than is delivered arterially. This has the result that a portion of the blood which is pumped into the area upstream of the canula during the venous phase, is sucked back during the arterial phase and is thus recirculated.
- a further aspect of recirculation is due to the hose system utilized.
- the entire hose system which lies between the venous pump and the arterial pump or clamp is subjected to the venous bath pressure. Because of the flexibility of the hoses and the air buffer present in the arterial pressure probe, the available volume of this part of the extra-corporeal tube system increases and the hose system balloons out.
- an additional volume of cleaned blood is stored in the tube system between the venous clamp and the arterial pump or clamp, opposite that in a pressure-less condition. In the immediately following arterial phase, this volume is recirculated. Since during this arterial phase an under-pressure develops, the available volume is reduced with respect to the pressureless condition.
- a further factor which determines the recirculation results from electronic or mechanical delays in the arterial and venous control circuits.
- the arterial pump is already activated while the venous pump is still in operation or the venous clamp is still open.
- Recirculation has a decisive influence on the effectiveness of the extra-corporeal circuit and thus upon, for example, the dialysis, as the volume of fluid running through the dialyzer is greater than the actual blood amount which leaves the fistula, by the recirculation portion.
- the basis of the present invention is provided by arranging to run the arterial and venous pumps at the beginning of their pump cycle at a high throughput rate.
- the invention is directed to an arrangement for the control of blood pumps in an extra-corporeal circuit having a single needle arrangement comprising a tribranched monolumenar canula, having one branch connectible to the patient and of the others, the first is connected to an arterial branch means comprising an arterial pump and an arterial pressure sensor and the second to a venous branch means, comprising a venous pump, a venous pressure sensor and a blood handling apparatus.
- the system further comprises a control entity and an arterial and a venous pump regulation arrangement which are connected to said arterial and said venous pressure sensor respectively, as well as to said arterial and said venous pump respectively.
- the said control entity is further connected with both of said pumps, whereby the signals from said pressure sensors, acting upon said arterial and said venous, pump regulation arrangements respectively act as activation arrangements for each of pumps and respectively.
- the arrangement further comprises, between the arterial and the venous pumps, a pressure sensor connected to the control entity and for the pressure-dependent control of said pumps.
- the improvement comprises driving the arterial pump and the venous pump upon activation, at a rate hiher than, suitably at a pumping rate of 1.2 to 3 times the normal throughput rate of the appropriate pumping phase.
- the pressure uptake means in the flow direction before the arterial pump to exercises pressure control of the arterial pump to obtain the predetermined under-pressure in the shortest possible time after the activation of the pump suitably by driving the arterial pump at its maximum throughput until the achievement of the desired under-pressure and after attainment of the predetermined under-pressure, maintaining the same at a constant level during the entire remaining arterial pumping phase by thereafter driving it with a sufficient throughput to maintain said under-pressure.
- the arterial pump prefferably delivers an under-pressure of -100 mmHg to -200 mmHg, relative to atmosphere and the venous pump to deliver a back-pressure of +200 mmHg to +300 mmHg, relative to atmosphere.
- the process of the present invention possesses a number of significant advantages.
- the advantage of the present invention can be more readily understood by a closer consideration of the time relationship of the recirculation.
- At the end of the venous pump phase there is a positive venous back pressure in the hose system.
- a certain volume of already cleaned blood is forced back into the arterial hose piece. It is thus always located in the segment of the hose system proximal to the canula.
- this blood volume stored in the arterial hose is the first to be moved and only thereafter the blood volume stored in the venous part of the hoses and only last the blood actually in the patient.
- this blood volume stored in the arterial hose is the first to be moved and only thereafter the blood volume stored in the venous part of the hoses and only last the blood actually in the patient.
- the pumps can be activated in accordance with a predetermined pump rate/time profile. It is, in fact, possible in accordance with this invention to activate the pumps by means of a pressure control mechanism.
- the arterial pump is so driven that after the activation of this pump the desired arterial under-pressure is achieved as rapidly as possible and this pressure is maintained at a constant level throughout the entire phase.
- the pressure control ensures that during a time determined by the control switches, the pump is driven at the maximum rate until the predetermined pressure value is obtained only then, is the pump run so that a constant flow is achieved without thereby bringing about damage of the fistula.
- the blood flow both from and to the patient is maximized. This leads to a substantial increase in the efficiency of the system.
- both in the arterial and venous branches pressure sensors are connected with a particular activation mechanism for regulating each pump device which in turn is connected to the control entity and that each regulating device is connected to each appropriate pump.
- the arrangement is provided with an additional regulating mechanism which controls the activation of the pump so that these run at maximum levels at the beginning of their activation and thereafter, their throughput is dropped to provide a constant throughput.
- FIG. 1 is a graphic representation of the pump rate/time profile of the arterial and venous pumps and
- FIG. 2 is a schematic representation of the arrangement of the present invention.
- FIG. 1 is shown in diagrammatic form illustrating the dependence of pump output plotted against activation time of the pump. From this it may be readily seen that upon activation of the pump this runs with a maximum throughput rate and thereafter, the throughput rate sinks to a constant value in order to abstract from and provide to the patient blood at a constant rate.
- FIG. 2 is a schematic representation of the arrangement of the invention as applied in single needled dialysis.
- the arrangement comprises a canula 10 which has a single lumen and which is connected to the patient.
- the canula 10 branches into an arterial branch 35 and a venous branch 45.
- a arterial pump 30 which is connected, downstream of pump 30 with an expansion chamber 21 by means of hose segment 36.
- Hose segment 46 runs out of the expansion chamber 21 to venous pump 40 which, in turn, is connected with the venous branch 45.
- a hose segment 41 Downstream of venous pump 40 there is provided a hose segment 41 which is connected to dialyzer 50. From dialyzer 50 the treated blood runs via hose segment 52 to a bubble elimination chamber 53, downstream of which is provided venous clamp 54 in branch 45.
- expansion chamber 21 is provided with a hydrophobic filter 23 which is connected to a further expansion chamber 22 whose exit end is equipped with pressure sensor 24.
- the signals from said pressure sensor 24 serve as a pressure/pressure control means by means of a control entity 25.
- Control entity 25 is operatively connected with a regulating arrangement 37 and a further regulating arrangement 47 which serve to activate the pumps 30 and 40 respectively.
- a pressure sensor 31 and 41 is provided in both the arterial branch as well as the venous branch which, serve to measure the suction pressure of the arterial pump 30 in the arterial branch 35 as well as, the forwarding pressure of the venous pump 40 in branch 45.
- the pressure sensor 31 is connected with the arterial branch 35 via hose segments 33 and 34 which have a hydrophobic filter 32 therebetween.
- the pressure sensor 41 is connected to bubble chamber 52 via hose segments 43 and 44 having a hydrophobic filter 42 therebetween.
- the output values of pressure sensors 31 and 41 are transmitted to regulating arrangements 37 and 47 respectively.
- Dialyzer 50 may be replaced by another blood handling arrangement for example, a plasma filter or an absorption arrangement.
- control arrangements 37 and 47 and the appropriate activating connections with the elements to be controlled corresponding, for example, to the control entity 25 are conventional in the art and therefore, is not illustrated in detail.
- the two control arrangements 37 and 47 ensure that after the activation of both the arterial and venous pumps by control arrangement 25 a predetermined suction pressure, as well as back pressure is provided wherein typically, the values lie (relative to atmosphere) between -100 mmHg and -200 mmHg for the arterial pump and +200 mmHg to +300 mmHg for the venous pumps.
Landscapes
- Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Anesthesiology (AREA)
- Vascular Medicine (AREA)
- Engineering & Computer Science (AREA)
- Emergency Medicine (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- External Artificial Organs (AREA)
Abstract
Description
Claims (15)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE3923836A DE3923836C1 (en) | 1989-07-19 | 1989-07-19 | |
DE3923836 | 1989-07-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
US5098373A true US5098373A (en) | 1992-03-24 |
Family
ID=6385344
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US07/552,782 Expired - Fee Related US5098373A (en) | 1989-07-19 | 1990-07-16 | Process for controlling blood pumps in the extra-corporeal circuit of a single needle arrangement and apparatus thereof |
Country Status (4)
Country | Link |
---|---|
US (1) | US5098373A (en) |
EP (1) | EP0408955B1 (en) |
JP (1) | JP2925259B2 (en) |
DE (2) | DE3923836C1 (en) |
Cited By (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5318511A (en) * | 1991-02-06 | 1994-06-07 | Hospal Industrie | Method and apparatus for controlling the circulation of blood in a single needle circuit |
US5382227A (en) * | 1991-02-06 | 1995-01-17 | Hospal Industrie | Apparatus and method for setting the level of a liquid in a chamber of an extracorporeal blood circuit |
US5507723A (en) * | 1994-05-24 | 1996-04-16 | Baxter International, Inc. | Method and system for optimizing dialysis clearance |
WO1998017334A1 (en) * | 1996-10-18 | 1998-04-30 | Hospal Ag | Method for determining the recirculation of blood in a vascular access and system for implementing same |
US6189388B1 (en) | 1997-11-12 | 2001-02-20 | Gambro, Inc. | Access flow monitoring using reversal of normal blood flow |
US6585675B1 (en) | 2000-11-02 | 2003-07-01 | Chf Solutions, Inc. | Method and apparatus for blood withdrawal and infusion using a pressure controller |
US6726647B1 (en) | 1998-10-23 | 2004-04-27 | Gambro Ab | Method and device for measuring access flow |
US20040186409A1 (en) * | 2003-01-28 | 2004-09-23 | Gambro Dasco S.P.A. | Apparatus and method for monitoring a vascular access of a patient subjected to an extracorporeal blood treatment |
US20050113735A1 (en) * | 1997-02-14 | 2005-05-26 | Brugger James M. | Blood flow control in a blood treatment device |
US20050131335A1 (en) * | 2003-12-11 | 2005-06-16 | Gambro Lundia Ab. | Switching device and apparatus for controlling flow of a fluid |
US20060009403A1 (en) * | 2002-03-07 | 2006-01-12 | Centre National De La Recherche Scientifique (Cnrs) | Dna demethylase antisense and chemotherapy combination |
US20060074369A1 (en) * | 2004-10-06 | 2006-04-06 | Nikkiso Co., Ltd. | Blood purification device |
US20090259164A1 (en) * | 2008-04-14 | 2009-10-15 | Etienne Pages | System and Method for Optimized Apheresis Draw and Return |
US20100010430A1 (en) * | 2002-07-19 | 2010-01-14 | Baxter International Inc. | Peritoneal dialysis systems and methods that regenerate dialysate |
US7794419B2 (en) | 2005-05-18 | 2010-09-14 | Gambro Lundia Ab | Apparatus for controlling blood flow in an extracorporeal circuit |
US7815852B2 (en) | 2003-11-20 | 2010-10-19 | Gambro Lundia Ab | Method, apparatus and software program for measurement of a parameter relating to a heart-lung system of a mammal |
US20110004141A1 (en) * | 2007-11-22 | 2011-01-06 | Wei Zhang | Method and arrangement for determining the recirculation in a fistula or the cardiopulmonary recirculation, and a blood treatment device comprising a device for determining the fistula recirculation or the cardiopulmonary recirculation part |
US20110178452A1 (en) * | 2008-10-02 | 2011-07-21 | Pascal Kopperschmidt | Device for extracorporeal blood treatment in single-needle operation mode |
US20120029409A1 (en) * | 2010-08-02 | 2012-02-02 | Hiram Rada | Extracorporeal blood treatment apparatus |
US20140100506A1 (en) * | 2008-04-14 | 2014-04-10 | Haemonetics Corporation | Three-Line Apheresis System and Method |
WO2017001358A1 (en) | 2015-06-29 | 2017-01-05 | Gambro Lundia Ab | Extracorporeal blood circuit for single-needle treatments |
US10758652B2 (en) | 2017-05-30 | 2020-09-01 | Haemonetics Corporation | System and method for collecting plasma |
US10792416B2 (en) | 2017-05-30 | 2020-10-06 | Haemonetics Corporation | System and method for collecting plasma |
US10946131B2 (en) | 2018-05-21 | 2021-03-16 | Fenwal, Inc. | Systems and methods for optimization of plasma collection volumes |
US11412967B2 (en) | 2018-05-21 | 2022-08-16 | Fenwal, Inc. | Systems and methods for plasma collection |
US11837357B2 (en) | 2011-05-18 | 2023-12-05 | Fenwal, Inc. | Plasma collection with remote programming |
US12033750B2 (en) | 2018-05-21 | 2024-07-09 | Fenwal, Inc. | Plasma collection |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5227049A (en) | 1990-08-20 | 1993-07-13 | Hospal Industrie | Single-needle circuit for circulating blood outside the body in blood treatment apparatus |
DE102007026010B4 (en) * | 2007-06-04 | 2010-11-25 | Fresenius Medical Care Deutschland Gmbh | Device for controlling a device for delivering blood and method for conveying blood in a blood line of an extracorporeal blood circulation of an extracorporeal blood treatment device |
JP7453835B2 (en) * | 2020-04-02 | 2024-03-21 | 旭化成メディカル株式会社 | blood processing system |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4464164A (en) * | 1982-09-24 | 1984-08-07 | Extracorporeal Medical Specialties, Inc. | Flowrate control for a blood flow system |
US4490135A (en) * | 1982-09-24 | 1984-12-25 | Extracorporeal Medical Specialties, Inc. | Single needle alternating blood flow system |
US4596550A (en) * | 1982-09-24 | 1986-06-24 | Baxter Travenol Laboratories, Inc. | Method and apparatus for ultrafiltration measurement in a two pump dialysis system |
US4702829A (en) * | 1984-12-07 | 1987-10-27 | Fresenius Ag | Hemodiafiltration apparatus |
US4758336A (en) * | 1986-01-14 | 1988-07-19 | Intermedicat Gmbh | Dialytic apparatus |
US4940455A (en) * | 1989-04-13 | 1990-07-10 | Cd Medical, Inc. | Method and apparatus for single needle dialysis |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4490134A (en) * | 1982-09-24 | 1984-12-25 | Extracorporeal Medical Specialties, Inc. | Dual phase blood flow system and method of operation |
-
1989
- 1989-07-19 DE DE3923836A patent/DE3923836C1/de not_active Expired - Lifetime
-
1990
- 1990-06-30 EP EP90112512A patent/EP0408955B1/en not_active Expired - Lifetime
- 1990-06-30 DE DE90112512T patent/DE59004872D1/en not_active Expired - Lifetime
- 1990-07-16 US US07/552,782 patent/US5098373A/en not_active Expired - Fee Related
- 1990-07-18 JP JP2190348A patent/JP2925259B2/en not_active Expired - Fee Related
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4464164A (en) * | 1982-09-24 | 1984-08-07 | Extracorporeal Medical Specialties, Inc. | Flowrate control for a blood flow system |
US4490135A (en) * | 1982-09-24 | 1984-12-25 | Extracorporeal Medical Specialties, Inc. | Single needle alternating blood flow system |
US4596550A (en) * | 1982-09-24 | 1986-06-24 | Baxter Travenol Laboratories, Inc. | Method and apparatus for ultrafiltration measurement in a two pump dialysis system |
US4702829A (en) * | 1984-12-07 | 1987-10-27 | Fresenius Ag | Hemodiafiltration apparatus |
US4758336A (en) * | 1986-01-14 | 1988-07-19 | Intermedicat Gmbh | Dialytic apparatus |
US4940455A (en) * | 1989-04-13 | 1990-07-10 | Cd Medical, Inc. | Method and apparatus for single needle dialysis |
Cited By (74)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5318511A (en) * | 1991-02-06 | 1994-06-07 | Hospal Industrie | Method and apparatus for controlling the circulation of blood in a single needle circuit |
US5382227A (en) * | 1991-02-06 | 1995-01-17 | Hospal Industrie | Apparatus and method for setting the level of a liquid in a chamber of an extracorporeal blood circuit |
US5507723A (en) * | 1994-05-24 | 1996-04-16 | Baxter International, Inc. | Method and system for optimizing dialysis clearance |
WO1998017334A1 (en) * | 1996-10-18 | 1998-04-30 | Hospal Ag | Method for determining the recirculation of blood in a vascular access and system for implementing same |
US6537240B2 (en) | 1996-10-18 | 2003-03-25 | Hospal Ag | Method for determining the recirculation of blood in a vascular access and a system for implementing same |
US20080306426A9 (en) * | 1997-02-14 | 2008-12-11 | Brugger James M | Blood flow control in a blood treatment device |
US20050113735A1 (en) * | 1997-02-14 | 2005-05-26 | Brugger James M. | Blood flow control in a blood treatment device |
US6189388B1 (en) | 1997-11-12 | 2001-02-20 | Gambro, Inc. | Access flow monitoring using reversal of normal blood flow |
US7955291B2 (en) | 1998-10-23 | 2011-06-07 | Gambro Lundia Ab | Method and apparatus for detecting access recirculation |
US6726647B1 (en) | 1998-10-23 | 2004-04-27 | Gambro Ab | Method and device for measuring access flow |
US20040168969A1 (en) * | 1998-10-23 | 2004-09-02 | Gambro Lundia Ab | Switch valve for an extracorporeal blood circuit and circuit including such a switch valve |
US7896831B2 (en) | 1998-10-23 | 2011-03-01 | Gambro Lundia Ab | Method and apparatus for calculating fluid flow rate |
US20090314063A1 (en) * | 1998-10-23 | 2009-12-24 | Gambro Lundia Ab | Method and apparatus for detecting access recirculation |
US7500958B2 (en) | 1998-10-23 | 2009-03-10 | Gambro Lundia Ab | Switch valve for an extracorporeal blood circuit and circuit including such a switch valve |
US7955289B2 (en) | 2000-11-02 | 2011-06-07 | Chf Solutions, Inc. | Method and apparatus for blood withdrawal and infusion using a pressure controller |
US7674237B2 (en) | 2000-11-02 | 2010-03-09 | Chf Solutions, Inc. | Method and apparatus for blood withdrawal and infusion using a pressure controller |
US20040030277A1 (en) * | 2000-11-02 | 2004-02-12 | Chf Solutions, Inc. | Method and apparatus for blood withdrawal and infusion using a pressure controller |
US6585675B1 (en) | 2000-11-02 | 2003-07-01 | Chf Solutions, Inc. | Method and apparatus for blood withdrawal and infusion using a pressure controller |
US7462161B2 (en) | 2000-11-02 | 2008-12-09 | Chf Solutions, Inc. | Method and apparatus for blood withdrawal and infusion using a pressure controller |
US20050230313A1 (en) * | 2000-11-02 | 2005-10-20 | Chf Solutions Inc. | Method and apparatus for blood withdrawal and infusion using a pressure controller |
US20090149795A1 (en) * | 2000-11-02 | 2009-06-11 | Chf Solutions, Inc. | Method and apparatus for blood withdrawal and infusion using a pressure controller |
US8702638B2 (en) | 2000-11-02 | 2014-04-22 | Gambro Uf Solutions, Inc. | Method for blood withdrawal and infusion using a pressure controller |
US20060009403A1 (en) * | 2002-03-07 | 2006-01-12 | Centre National De La Recherche Scientifique (Cnrs) | Dna demethylase antisense and chemotherapy combination |
US8815095B2 (en) * | 2002-07-19 | 2014-08-26 | Baxter International Inc. | Peritoneal dialysis systems and methods that regenerate dialysate |
US20100010430A1 (en) * | 2002-07-19 | 2010-01-14 | Baxter International Inc. | Peritoneal dialysis systems and methods that regenerate dialysate |
US20040186409A1 (en) * | 2003-01-28 | 2004-09-23 | Gambro Dasco S.P.A. | Apparatus and method for monitoring a vascular access of a patient subjected to an extracorporeal blood treatment |
US7749184B2 (en) | 2003-01-28 | 2010-07-06 | Gambro Lundia Ab | Apparatus and method of monitoring a vascular access of a patient subjected to an extracorporeal blood treatment |
US20070112289A1 (en) * | 2003-01-28 | 2007-05-17 | Gambro Lundia Ab | Apparatus and method of monitoring a vascular access of a patient subjected to an extracorporeal blood treatment |
US7172570B2 (en) | 2003-01-28 | 2007-02-06 | Gambro Lundia Ab | Apparatus and method for monitoring a vascular access of a patient subjected to an extracorporeal blood treatment |
US7815852B2 (en) | 2003-11-20 | 2010-10-19 | Gambro Lundia Ab | Method, apparatus and software program for measurement of a parameter relating to a heart-lung system of a mammal |
US20050131335A1 (en) * | 2003-12-11 | 2005-06-16 | Gambro Lundia Ab. | Switching device and apparatus for controlling flow of a fluid |
US7836914B2 (en) | 2003-12-11 | 2010-11-23 | Gambro Lundia Ab | Switching device and apparatus for controlling flow of a fluid |
US7575562B2 (en) * | 2004-10-06 | 2009-08-18 | Nikkiso Co., Ltd. | Blood purification device |
US20060074369A1 (en) * | 2004-10-06 | 2006-04-06 | Nikkiso Co., Ltd. | Blood purification device |
US7794419B2 (en) | 2005-05-18 | 2010-09-14 | Gambro Lundia Ab | Apparatus for controlling blood flow in an extracorporeal circuit |
US20110004141A1 (en) * | 2007-11-22 | 2011-01-06 | Wei Zhang | Method and arrangement for determining the recirculation in a fistula or the cardiopulmonary recirculation, and a blood treatment device comprising a device for determining the fistula recirculation or the cardiopulmonary recirculation part |
US8858486B2 (en) * | 2007-11-22 | 2014-10-14 | Fresenius Medical Care Deutschland Gmbh | Method and arrangement for determining the recirculation in a fistula or the cardiopulmonary recirculation, and a blood treatment device comprising a device for determining the fistula recirculation or the cardiopulmonary recirculation part |
US8702637B2 (en) * | 2008-04-14 | 2014-04-22 | Haemonetics Corporation | System and method for optimized apheresis draw and return |
US20110178453A1 (en) * | 2008-04-14 | 2011-07-21 | Haemonetics Corporation | System and Method for Optimized Apheresis Draw and Return |
US9364600B2 (en) | 2008-04-14 | 2016-06-14 | Haemonetics Corporation | System and method for optimized apheresis draw and return |
US9095665B2 (en) * | 2008-04-14 | 2015-08-04 | Haemonetics Corporation | Three-line apheresis system and method |
US20090259164A1 (en) * | 2008-04-14 | 2009-10-15 | Etienne Pages | System and Method for Optimized Apheresis Draw and Return |
CN102046224B (en) * | 2008-04-14 | 2014-08-13 | 赫摩耐提克斯公司 | System and method for optimized apheresis draw and return |
US8647289B2 (en) | 2008-04-14 | 2014-02-11 | Haemonetics Corporation | System and method for optimized apheresis draw and return |
US20140100506A1 (en) * | 2008-04-14 | 2014-04-10 | Haemonetics Corporation | Three-Line Apheresis System and Method |
US20110178452A1 (en) * | 2008-10-02 | 2011-07-21 | Pascal Kopperschmidt | Device for extracorporeal blood treatment in single-needle operation mode |
US8500671B2 (en) | 2008-10-02 | 2013-08-06 | Fresenius Medical Care Deutschland Gmbh | Device for extracorporeal blood treatment in single-needle operation mode |
US20130178781A1 (en) * | 2010-08-02 | 2013-07-11 | Gambro Lundia Ab | Extracorporeal blood treatment apparatus |
US8394047B2 (en) * | 2010-08-02 | 2013-03-12 | Gambro Lundia Ab | Extracorporeal blood treatment apparatus |
US8956317B2 (en) * | 2010-08-02 | 2015-02-17 | Gambro Lundia Ab | Extracorporeal blood treatment apparatus |
EP2415491A1 (en) * | 2010-08-02 | 2012-02-08 | Gambro Lundia AB | Extracorporeal blood treatment apparatus |
US20120029409A1 (en) * | 2010-08-02 | 2012-02-02 | Hiram Rada | Extracorporeal blood treatment apparatus |
US11837357B2 (en) | 2011-05-18 | 2023-12-05 | Fenwal, Inc. | Plasma collection with remote programming |
WO2017001358A1 (en) | 2015-06-29 | 2017-01-05 | Gambro Lundia Ab | Extracorporeal blood circuit for single-needle treatments |
US10758652B2 (en) | 2017-05-30 | 2020-09-01 | Haemonetics Corporation | System and method for collecting plasma |
US11738124B2 (en) | 2017-05-30 | 2023-08-29 | Haemonetics Corporation | System and method for collecting plasma |
US10980926B2 (en) | 2017-05-30 | 2021-04-20 | Haemonetics Corporation | System and method for collecting plasma |
US10980934B2 (en) | 2017-05-30 | 2021-04-20 | Haemonetics Corporation | System and method for collecting plasma |
US12186474B2 (en) | 2017-05-30 | 2025-01-07 | Haemonetics Corporation | System and method for collecting plasma |
US12171916B2 (en) | 2017-05-30 | 2024-12-24 | Haemonetics Corporation | System and method for collecting plasma |
US10792416B2 (en) | 2017-05-30 | 2020-10-06 | Haemonetics Corporation | System and method for collecting plasma |
US11110216B2 (en) | 2018-05-21 | 2021-09-07 | Fenwal, Inc. | Systems and methods for optimization of plasma collection volumes |
US11383013B2 (en) | 2018-05-21 | 2022-07-12 | Fenwal, Inc. | Systems and methods for optimization of plasma collection volumes |
US11412967B2 (en) | 2018-05-21 | 2022-08-16 | Fenwal, Inc. | Systems and methods for plasma collection |
US11730873B2 (en) | 2018-05-21 | 2023-08-22 | Fenwal, Inc. | Systems and methods for optimization of plasma collection volumes |
US11369724B2 (en) | 2018-05-21 | 2022-06-28 | Fenwal, Inc. | Systems and methods for optimization of plasma collection volumes |
US11801001B2 (en) | 2018-05-21 | 2023-10-31 | Fenwal, Inc. | Systems and methods for plasma collection |
US11285251B2 (en) | 2018-05-21 | 2022-03-29 | Fenwal, Inc. | Systems and methods for optimization of plasma collection volumes |
US12033750B2 (en) | 2018-05-21 | 2024-07-09 | Fenwal, Inc. | Plasma collection |
US12083258B2 (en) | 2018-05-21 | 2024-09-10 | Fenwal, Inc. | Systems and methods for optimization of plasma collection volumes |
US12144624B2 (en) | 2018-05-21 | 2024-11-19 | Fenwal, Inc. | Systems and methods for plasma collection |
US10946131B2 (en) | 2018-05-21 | 2021-03-16 | Fenwal, Inc. | Systems and methods for optimization of plasma collection volumes |
US11097042B2 (en) | 2018-05-21 | 2021-08-24 | Fenwal, Inc. | Systems and methods for optimization of plasma collection volumes |
US12237078B2 (en) | 2018-05-21 | 2025-02-25 | Fenwal, Inc. | Plasma collection |
Also Published As
Publication number | Publication date |
---|---|
EP0408955A3 (en) | 1991-06-05 |
DE59004872D1 (en) | 1994-04-14 |
JPH03131268A (en) | 1991-06-04 |
JP2925259B2 (en) | 1999-07-28 |
DE3923836C1 (en) | 1990-09-20 |
EP0408955A2 (en) | 1991-01-23 |
EP0408955B1 (en) | 1994-03-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5098373A (en) | Process for controlling blood pumps in the extra-corporeal circuit of a single needle arrangement and apparatus thereof | |
US4885001A (en) | Pump with plural flow lines | |
US3985134A (en) | Extracorporeal blood circuit | |
US5928179A (en) | Method and apparatus for creating pulsatile flow in a cardiopulmonary bypass circuit | |
US4014317A (en) | Multipurpose cardiocirculatory assist cannula and methods of use thereof | |
US3830234A (en) | Dialysis control system and method | |
US5413558A (en) | Selective aortic perfusion system for use during CPR | |
US5171207A (en) | Apparatus and method of use for pulsatile blood flow | |
US6896664B2 (en) | Apparatus for irrigating a body cavity with a liquid | |
JP2000107283A (en) | Dialysis apparatus and washing priming method | |
JPS63105769A (en) | Method and apparatus for allowing two kinds of liquid for artificial kidney to feed out as continuous flow in same amount by pump | |
US20090221949A1 (en) | Device and method for circulatory isolation and treatment of a part of a body | |
US6290669B1 (en) | Peritoneal dialysis apparatus and method | |
Cooley | Development of the roller pump for use in the cardiopulmonary bypass circuit | |
AU6041190A (en) | Combined hemofiltration and hemodialysis system | |
JP3322987B2 (en) | Diafiltration equipment | |
WO2022183590A1 (en) | Flow guide control system | |
JPH0614964B2 (en) | Method and device for automatic priming treatment of blood purification circuit | |
CA1062623A (en) | Single cannula dialysis control | |
US10471200B2 (en) | Blood purification apparatus | |
RU2153360C2 (en) | Blood injection apparatus | |
JP2019092643A (en) | Single needle type blood purification device | |
US11931498B2 (en) | Blood purification apparatus | |
JPH05137780A (en) | Blood cleaning method, venous pressure measuring instrument, automatic blood cleaning device, and blood circuit with branch pipe for measuring venous pressure | |
JP3013942B2 (en) | Dialysis machine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: FRESENIUS AG, GLUCKENSTEINWEG 5, D-6380 BAD HOMBUR Free format text: ASSIGNMENT OF ASSIGNORS INTEREST.;ASSIGNOR:POLASCHEGG, HANS-DIETRICH;REEL/FRAME:005389/0379 Effective date: 19900710 |
|
FEPP | Fee payment procedure |
Free format text: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY |
|
FPAY | Fee payment |
Year of fee payment: 4 |
|
FPAY | Fee payment |
Year of fee payment: 8 |
|
REMI | Maintenance fee reminder mailed | ||
LAPS | Lapse for failure to pay maintenance fees | ||
FP | Lapsed due to failure to pay maintenance fee |
Effective date: 20040324 |
|
STCH | Information on status: patent discontinuation |
Free format text: PATENT EXPIRED DUE TO NONPAYMENT OF MAINTENANCE FEES UNDER 37 CFR 1.362 |